Skip to main content

ANAPLASTIC THYROID CANCER

Tracking # 20-816741

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

ANAPLASTIC THYROID CARCINOMA, ALSO KNOWN AS UNDIFFERENTIATED THYROID CARCINOMA, IS A RARE, HIGHLY AGGRESSIVE MALIGNANT TUMOR ACCOUNTING FOR 2 TO 3 PERCENT OF ALL THYROID GLAND NEOPLASMS. ANAPLASTIC THYROID CARCINOMA CONTINUES TO BE ONE OF THE MOST DEADLY DISEASES WORLDWIDE AND CARRIES A VERY POOR PROGNOSIS. IN ADDITION TO CONSIDERABLE LOCAL INVASION, ANAPLASTIC THYROID CARCINOMA OFTEN PRESENTS WITH METASTATIC SPREAD TO REGIONAL LYMPH NODES AND DISTANT SITES. THIS ACTIVITY EXAMINES WHEN CLINICIANS SHOULD CONSIDER THIS CONDITION ON DIFFERENTIAL DIAGNOSIS AND HOW TO DIAGNOSE IT PROPERLY. THIS ACTIVITY HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE CARE OF PATIENTS WITH THIS CONDITION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I